Initial Submission : May 31, 2024 June 7, 2024
Decision Notification: August 15, 2024
Final Submission: September 15, 2024
All submissions must be in English. Only original papers that are not submitted or published in other conferences or journals will be considered. Submissions are invited for:
Regular papers must be between 4 (minimum) and 6 (maximum) pages in the final version. PDF files will be limited to 2 MB in size.
Extended (2-page) abstracts (NOT published on IFAC PapersOnLine)
Invited sessions, consisting of up to six regular papers, around a common theme of interest to the CPHS community
See the Authors' guide for further details. Paper and session proposals can be submitted using the PaperPlaza Conference Manuscript Management System. The submission link for CPHS 2024 can be found in the list of tables.
Detailed submission instructions can be found here.
After the peer-review process, the accepted papers will be published in IFAC-PapersOnline. High-quality papers will be encouraged to be extended and submitted for a publication on the special section on CPHS in Annual Reviews in Control or the second CPHS book.
All publication material submitted for presentation at an IFAC-sponsored meeting (Congress, Symposium, Conference, Workshop) must be original and hence cannot be already published, nor can it be under review elsewhere. The authors take responsibility for the material that has been submitted. IFAC-sponsored conferences will abide by the highest standard of ethical behavior in the review process as explained on the Elsevier webpage, and the authors will abide by the IFAC publication ethics guidelines.
Accepted regular papers that have been presented at an IFAC meeting will be published in the proceedings of the event using the open-access IFAC-PapersOnLine series hosted on ScienceDirect.
To this end, the author(s) must grant exclusive publishing rights to IFAC under a Creative Commons license when they submit the final version of the paper. The copyright belongs to the authors, who have the right to share the paper in the same terms allowed by the end user license, and retain all patent, trademark and other intellectual property rights (including research data).